Nuclear factor (NF) kappa B is a transcription factor that controls the tra
nscription of a variety of cellular genes regulating the inflammatory respo
nse. Many proinflammatory cytokines are transcriptionally regulated by NF-k
appa B, and their increased expression has been implicated in the pathogene
sis of inflammatory bowel disease (IBD). Even though it seemed clear that t
he increase in proinflammatory cytokine production in IBD is crucial for th
e initiation and perpetuation of chronic intestinal inflammation, the eleme
nts governing this dysregulation of enhanced cytokine production remained u
nclear. This review discusses a series of recent studies:that demonstrate t
he activation of NF-kappa B in the inflamed mucosa, and that shed new light
on the central pathogenic role of NF-kappa B in chronic intestinal inflamm
ation. In addition to describing the activation of NF-kappa B, excitement h
as been generated by reports that define the molecular targets of anti-infl
ammatory agents, and that demonstrate the effective blockade of NF-kappa B
in intestinal inflammation. These new insights into the activation and inhi
bition of NF-kappa B have opened new and promising avenues for a more-speci
fic treatment of chronic intestinal inflammation.